Evidence map›Paper›PMID 28887873›Full record

ArticleClinical and translational science2018

The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences.

Douglas A Luke, Cathy C Sarli, Amy M Suiter, Bobbi J Carothers, Todd B Combs, Jae L Allen, Courtney E Beers, Bradley A Evanoff

Abstract readValidation Study
In one paragraph

Article in Clinical and translational science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Embracing complexity: An opportunity for developmental evaluation.Journal of clinical and translational science · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. So what? Elevating the impact of implementation science.Implementation science communications · 2025
    Article
  17. Article
  18. Thoughts on Future Directions for Translation of Psychological Treatment: Commentary on Bitterman et al.Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association · 2025
    Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Douglas A LukeCenter for Public Health Systems Science, George Warren Brown School of Social Work, Washington University in St. Louis, Missouri, USA.
Cathy C SarliBecker Medical Library, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Amy M SuiterBecker Medical Library, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Bobbi J CarothersCenter for Public Health Systems Science, George Warren Brown School of Social Work, Washington University in St. Louis, Missouri, USA.
Todd B CombsCenter for Public Health Systems Science, George Warren Brown School of Social Work, Washington University in St. Louis, Missouri, USA.
Jae L AllenInstitute of Clinical and Translational Sciences (ICTS), Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Courtney E BeersInstitute of Clinical and Translational Sciences (ICTS), Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Bradley A EvanoffDivision of General Medical Sciences, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Center for Diabetes Translation Research P30DK092950 · NIDDK · WASHINGTON UNIVERSITY · PI Ross C Brownson, Debra Haire-Joshu · 2011 to 2026
$11.7M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NIDDK NIH HHS P30 DK092950
6 · The paper itself

Abstract

We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in-house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.

Indexed as

Systems AnalysisBiomarkersContraceptionCreutzfeldt-Jakob SyndromeFeasibility StudiesFemaleHumansKidney NeoplasmsLogistic ModelsTranslational Research, BiomedicalBiomarkers

Identifiers

PMID28887873
PMCPMC5759746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.